IDDF2022-ABS-0058 Efficacy and response predictors of percutaneous radiofrequency ablation for treatment of intermediate stage hepatocellular carcinoma: a controlled clinical trial

Autor:	Ragaey Ahmad Eid, Manar Ahmed Kamal, Abdelrahman M Attia, Ali M Abdel Fattah, Rabab Afify Mohamed, Mohammad M Tawfik, Alaa Farouk Haseeb
Rok vydání:	2022
Zdroj:	Clinical Hepatology.
DOI:	10.1136/gutjnl-2022-iddf.92
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::13233d7231cdb8d9637ed0b175d440e3 https://doi.org/10.1136/gutjnl-2022-iddf.92 Zobrazit plný text záznamu